emjreviews.com6 天
SGLT2 Inhibitors Reduce Cardiovascular Risks in Patients with Type 2 Diabetes
NEW research has revealed that sodium-glucose cotransporter 2 inhibitors (SGLT2is) are associated with an 18% reduction in ...